These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3274430)

  • 21. Digoxin in the 1980s.
    Minson RB; McRitchie RJ
    Med J Aust; 1987 Oct; 147(8):403-7, 410. PubMed ID: 3309595
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokinetics.
    Robieux I; Dorian P; Klein J; Chung D; Zborowska-Sluis D; Ogilvie R; Koren G
    J Clin Pharmacol; 1992 Apr; 32(4):338-43. PubMed ID: 1569236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Digoxin pharmacokinetics in right-ventricular circulatory insufficiency].
    Halawa B; Mazurek W; Kasprzak-Wójtowicz J
    Pol Tyg Lek; 1980 Aug; 35(32):1209-12. PubMed ID: 7433202
    [No Abstract]   [Full Text] [Related]  

  • 24. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
    Ludwin D; Bennett KJ; Grace EM; Buchanan WW; Bensen W; Bombardier C; Tugwell PX
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):367-70. PubMed ID: 3381299
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporine related hypertension and nephrotoxicity in rat heart transplantation.
    Kanehira A; Shida T; Nakamura H; Wakita N; Ito H; Nakamura K
    Dev Toxicol Environ Sci; 1986; 14():141-7. PubMed ID: 3549246
    [No Abstract]   [Full Text] [Related]  

  • 26. Self-reported change in physical symptoms from cyclosporine-based therapy to azathioprine-based therapy in heart transplant recipients.
    Lough ME; Miller JL; Gamberg P
    J Heart Transplant; 1986; 5(4):322-6. PubMed ID: 3305825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Digitoxin, digoxin. Principles and rules of use, dosage].
    Lechat P
    Rev Prat; 1994 Jun; 44(12):1695-9. PubMed ID: 7939249
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine nephrotoxicity: pathogenetic factors and prevention.
    Ryffel B; Mihatsch MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1635-6. PubMed ID: 3274392
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic cyclosporine-associated nephrotoxicity.
    Porter GA; Bennett WM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):204-9. PubMed ID: 3515689
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients.
    Ben Hmida M; Baumelou A; Desruesnnes M; Cabrol A; Pavie A; Grandjbakhch I; Cabrol C
    Transplant Proc; 1995 Oct; 27(5):2725-7. PubMed ID: 7482891
    [No Abstract]   [Full Text] [Related]  

  • 32. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
    Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine immunosuppression.
    Canafax DM; Ascher NL
    Clin Pharm; 1983; 2(6):515-24. PubMed ID: 6360494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of the pharmacokinetic, pharmacodynamic and clinical studies of digoxin use].
    Kukes VG; Volkov RIu; Ibadova D; Shokhor VIa
    Ter Arkh; 1985; 57(12):59-62. PubMed ID: 4089770
    [No Abstract]   [Full Text] [Related]  

  • 35. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency.
    Denys BG; Reddy PS; Uretsky BF
    Am J Cardiol; 1989 Aug; 64(5):405-6. PubMed ID: 2667306
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of cyclosporine-induced nephrotoxicity by immunoperoxidase analysis of renal allograft biopsies.
    Kolbeck PC; Wolfe JA; Burchette J; Sanfilippo F
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1781-4. PubMed ID: 3547883
    [No Abstract]   [Full Text] [Related]  

  • 37. Morphologic diagnosis of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Semin Diagn Pathol; 1988 Feb; 5(1):104-21. PubMed ID: 3281200
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine approved for kidney, liver, and heart transplants.
    FDA Drug Bull; 1984 Apr; 14(1):6-7. PubMed ID: 6376250
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of digoxin administered to horses with congestive heart failure.
    Sweeney RW; Reef VB; Reimer JM
    Am J Vet Res; 1993 Jul; 54(7):1108-11. PubMed ID: 8368606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine in heart and heart-lung transplantation.
    Modry DL; Oyer PE; Jamieson SW; Stinson EB; Baldwin JC; Reitz BA; Dawkins KD; McGregor CG; Hunt SA; Moran M
    Can J Surg; 1985 May; 28(3):274-80, 282. PubMed ID: 3922606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.